INC Research expands in South Korea

Monday, September 17, 2012 09:27 AM

INC Research, a therapeutically focused CRO based in Raleigh, N.C., has opened a facility in Seoul, South Korea to manage the growing demand for world-class clinical development programs.

"The South Korean government has renewed its focus on healthcare and clinical development leading to a dramatic increase in the opportunities for biopharmaceutical companies' drug development programs," said Kelvin Logan, PhD, president of Asia/Pacific, INC Research. "Our expanded team is equipped to help customers take advantage of the benefits of conducting clinical trials in this region, while navigating through the developing regulatory environment and leveraging support resources."

The company's South Korean team is primarily focused on study start-up and clinical operations activities around key therapeutic areas. The new office is located in Gangnam-gu, Seoul, in the central business district with easy access to client and business partners and will be managed by Dr. Jessica Liu, general manager, and Lee Sun-Mee, associate director of clinical operations and site head.

INC Research provides phase I to IV clinical development services in the Asia/Pacific region with extensive coverage across China, India, Australia, Singapore, Philippines, South Korea, Taiwan, Hong Kong, Malaysia, Thailand and New Zealand. The company has the broad regional presence, therapeutic expertise, operational excellence and ability to apply international insights to local projects to meet the needs of drug developers.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs